Related Experiment Video
Updated: Nov 24, 2025
09:54
A Model to Simulate Clinically Relevant Hypoxia in Humans
Published on: December 22, 2016
9.1K
Silent hypoxaemia in COVID-19 patients
Tatum S Simonson1, Tracy L Baker2, Robert B Banzett3
1Division of Pulmonary, Critical Care, & Sleep Medicine, Department of Medicine, University of California, San Diego, CA, USA.
The Journal of Physiology
|December 21, 2020
Summary
The clinical presentation of COVID-19 varies greatly, with some patients experiencing
Area of Science:
- Medical Research
- Infectious Diseases
- Pulmonology
Background:
- COVID-19 (Coronavirus Disease 2019) presents with a wide spectrum of symptoms.
- Severe respiratory failure affects a subset of patients, but the reasons for this variability remain unclear.
- 'Happy hypoxia,' characterized by absent dyspnea despite low oxygen levels, is a debated phenomenon in COVID-19.
Purpose of the Study:
- To investigate the underlying causes of variable clinical presentations in COVID-19.
- To explore the respiratory and neurological factors contributing to silent hypoxemia.
- To define research priorities for understanding COVID-19 symptom variability.
Main Methods:
- Review of existing literature and clinical observations.
- Analysis of reported cases of 'happy hypoxia' and silent hypoxemia.
- Identification of key physiological and neurological mechanisms.
Main Results:
- The variability in COVID-19 presentation is not fully understood.
- Both respiratory and neurological factors may play a role in silent hypoxemia.
- Further research is needed to elucidate these mechanisms.
Conclusions:
- Understanding the variability in COVID-19 clinical presentation is critical.
- Investigating respiratory and neurological components is essential for explaining silent hypoxemia.
- Prioritizing future research will aid in managing COVID-19 patients effectively.
Related Concept Videos
01:21Acute Respiratory Failure-II
770
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
770
01:23Hypoxia
1.6K
Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
1.6K
01:23Acute Respiratory Failure-IV
366
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
366
01:16Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
436
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
436
01:25Hyperpnea and Hyperventilation
1.8K
Hyperventilation refers to a higher-than-normal rate and depth of breathing, often associated with anxiety attacks. This excessive breathing surpasses the body's need to expel CO2, leading to a condition known as hypocapnia - an unusually low level of carbon dioxide in the blood. Hypocapnia can constrict cerebral blood vessels, reducing blood flow to the brain, which may result in dizziness or fainting. Early signs include tingling and muscle spasms in the hands and face, caused by falling...
1.8K
01:19Respiratory Assessment: Purpose and Indications
1.4K
Respiratory assessment is a cornerstone of nursing assessments, crucial for the early detection of patient deterioration. This evaluation transcends routine procedures, representing a critical skill nurses must master to ensure optimal patient care.
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
1.4K